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Background: There has been significant improvement in the quality of care for acute myocardial infarctions over the past decade. However, 
relatively little is known about the quality of preventive care received by patients prior to their first myocardial infarction (MI). The aim of this study 
was to determine the screening rates for diabetes and hyperlipidemia and the prevalence of undiagnosed diabetes and hyperlipidemia in patients 
who present to hospital with their first MI.
Methods: We conducted a retrospective, population-based cohort analysis of 5,688 patients admitted with their first MI to 96 acute care hospitals 
in Ontario, Canada, from April 2004 to March 2005 in the Enhanced Feedback For Effective Cardiac Treatment (EFFECT) clinical study database 
(ClinicalTrials.gov Identifier: NCT00187460). We calculated rates of screening for diabetes and hyperlipidemia according to the Canadian Diabetes 
Association Guidelines and the Canadian Cardiovascular Society Dyslipidemia Guidelines. We also determined the proportion of patients that met 
diagnostic criteria for diabetes and hyperlipidemia at admission with no prior documented diagnosis of these conditions. 
Results: Among 5,688 eligible patients, 4,676 (82.2%) had at least one previously documented modifiable risk factor of diabetes, hyperlipidemia, 
smoking or hypertension. 36.5% of patients did not receive serum cholesterol screening in the five years preceding their MI and 27.2% of patients 
did not receive a fasting blood glucose or hemoglobin A1C in the three years prior to their MI. Screening rates for hyperlipidemia and diabetes 
generally increased with age and they were similar across sex and socio-economic status. 14.7% of patients had undiagnosed diabetes or 
hyperlipidemia that was not diagnosed prior to their MI.
Conclusions: A significant number of patients admitted with their first MI were not screened for important modifiable risk factors and/or had 
undiagnosed diabetes or hyperlipidemia at the time of their initial presentation. Many opportunities for prevention of coronary disease are being 
missed and more emphasis is needed on screening and identifying risk factors prior to the development of acute coronary disease.
